Last reviewed · How we verify
Astragalus
At a glance
| Generic name | Astragalus |
|---|---|
| Sponsor | Fujian Medical University Union Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Acute Effects of Posterior Talar Glide Mobilization (NA)
- A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle (PHASE3)
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. (NA)
- Effects of Mobilization With Movement Floss Band (MWF) Application (NA)
- The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula (PHASE2)
- Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway (NA)
- Chinese Adaptive Randomised Pneumonia Trial With Respiratory Failure (PHASE4)
- Effect of JointIQ on Joint Discomfort in Healthy Subjects (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Astragalus CI brief — competitive landscape report
- Astragalus updates RSS · CI watch RSS
- Fujian Medical University Union Hospital portfolio CI